The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...
Skin care aficionados everywhere are making space for a dermatologist-backed, budget-friendly brand in their medicine ...
the current widely prescribed type of medicine aimed at obesity and diabetes. Roche has been making the case that the obesity market is large enough for it to enter the field, if a bit later than ...
The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...
Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...